SOPHiA GENETICS (SOPH) Operating Leases (2020 - 2025)

SOPHiA GENETICS (SOPH) has 6 years of Operating Leases data on file, last reported at $12.6 million in Q4 2025.

• For the quarter ending Q4 2025, Operating Leases fell 13.81% year-over-year to $12.6 million; the trailing twelve-month figure through Dec 2025 stood at $12.6 million (down 13.81% YoY), and the FY2025 full-year result was $12.6 million, down 13.81% from the prior year.
• Operating Leases retreated to $12.6 million in Q4 2025, from $13.2 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $16.7 million in Q4 2022 to a low of $1.9 million in Q3 2024.
• A 5-year average of $12.9 million and a median of $14.2 million in 2024 frame the typical range for Operating Leases.
• Across the five-year window, Operating Leases plunged 87.3% in 2024 and jumped 593.84% in 2025, its largest moves.
• Tracing SOPH's Operating Leases over 5 years: stood at $13.1 million in 2021, then climbed by 28.21% to $16.7 million in 2022, then dropped by 6.39% to $15.7 million in 2023, then decreased by 6.83% to $14.6 million in 2024, then dropped by 13.81% to $12.6 million in 2025.
• Business Quant data shows SOPH's Operating Leases at $12.6 million in Q4 2025, $13.2 million in Q3 2025, and $13.9 million in Q2 2025.